Frank van Leth

Associate Professor Health Sciences

Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.


Journal article


F. van Leth, G. Günther, H. Hoffmann, C. Lange
American Journal of Respiratory and Critical Care Medicine, 2017

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
van Leth, F., Günther, G., Hoffmann, H., & Lange, C. (2017). Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria. American Journal of Respiratory and Critical Care Medicine.


Chicago/Turabian   Click to copy
Leth, F. van, G. Günther, H. Hoffmann, and C. Lange. “Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.” American Journal of Respiratory and Critical Care Medicine (2017).


MLA   Click to copy
van Leth, F., et al. “Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.” American Journal of Respiratory and Critical Care Medicine, 2017.


BibTeX   Click to copy

@article{f2017a,
  title = {Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.},
  year = {2017},
  journal = {American Journal of Respiratory and Critical Care Medicine},
  author = {van Leth, F. and Günther, G. and Hoffmann, H. and Lange, C.}
}